Biofrontera (BFRI) Cash on Hand per Share

Corporate emblem and logo of Biofrontera, Inc. (BFRI)

Biofrontera Inc. (BFRI) generates revenue based on the sales of the Ameluz system and BF-RhodoLED lamps. Cash per share illustrates current liquidity, with the value of 0.18 representing the most recent figure. The monetization of proprietary photodynamic methods ensures stable demand. Currently, the company is seeking to expand insurance reimbursements and increase its presence in the keratosis therapy niche while remaining in a maturity phase.

Biofrontera, Inc. - BFRI Cash per Single Share (period 07/04/2022 - 11/20/2026)

Analytical breakdowns for Biofrontera Inc.

- cash position and cash flow details:
Summary company analysis:BFRI, Biofrontera Inc
Original product of Biofrontera Inc.

Biofrontera Inc. (BFRI) operational strategy to expand distribution through medical alliances is directly reflected in the dynamics of the current liquidity level per share. This metric compares market capitalization with available cash reserves to determine the business's internal margin of safety. The calculation allows for an assessment of default protection during periods of volatility and the potential for return on equity. For a company that has eschewed acquisitions, this indicator confirms the effectiveness of organic growth. A high value indicates the reliability of assets.